Primary |
Preoperative Care |
64.8% |
Therapeutic Skin Care Topical |
10.7% |
Infection Prophylaxis |
5.7% |
Surgery |
5.7% |
Antibiotic Prophylaxis |
1.6% |
Sepsis |
1.6% |
Skin Disorder |
1.6% |
Anti-infective Therapy |
0.8% |
Intraoperative Care |
0.8% |
Nail Operation |
0.8% |
Postoperative Care |
0.8% |
Procedural Complication |
0.8% |
Removal Of Inert Matter From Skin Or Subcutaneous Tissue |
0.8% |
Therapeutic Procedure |
0.8% |
Tibial Torsion |
0.8% |
Type 2 Diabetes Mellitus |
0.8% |
Urticaria |
0.8% |
|
Skin Irritation |
16.5% |
Application Site Rash |
15.5% |
Rash |
7.2% |
Anaphylactic Reaction |
6.2% |
Burns Second Degree |
6.2% |
Application Site Pruritus |
5.2% |
Blister |
5.2% |
Rash Papular |
5.2% |
Rash Pruritic |
4.1% |
Scratch |
4.1% |
Application Site Reaction |
3.1% |
Erythema |
3.1% |
Excoriation |
3.1% |
Staphylococcal Infection |
3.1% |
Accidental Exposure |
2.1% |
Application Site Erosion |
2.1% |
Application Site Scar |
2.1% |
Drug Hypersensitivity |
2.1% |
Eczema Weeping |
2.1% |
Iatrogenic Injury |
2.1% |
|
Secondary |
Preoperative Care |
31.3% |
Pulmonary Arterial Hypertension |
31.3% |
Low Back Pain |
12.5% |
Surgery |
12.5% |
Antibiotic Prophylaxis |
6.3% |
Haemodialysis |
6.3% |
|
Application Site Pruritus |
9.1% |
Catheter Site Inflammation |
9.1% |
Catheter Site Rash |
9.1% |
Hospitalisation |
9.1% |
No Therapeutic Response |
9.1% |
Purulent Discharge |
9.1% |
Rash Erythematous |
9.1% |
Restless Legs Syndrome |
9.1% |
Therapy Cessation |
9.1% |
Vomiting |
9.1% |
Wheezing |
9.1% |
|
Concomitant |
Low Back Pain |
68.8% |
Pain |
15.6% |
Back Pain |
6.3% |
Joint Pain |
3.1% |
Product Used For Unknown Indication |
3.1% |
Sacroiliitis |
3.1% |
|
Meningitis |
53.3% |
Hospitalisation |
13.3% |
Nuclear Magnetic Resonance Imaging |
6.7% |
Unevaluable Event |
6.7% |
Cerebrovascular Accident |
3.3% |
Headache |
3.3% |
Infusion Site Irritation |
3.3% |
Malaise |
3.3% |
Photophobia |
3.3% |
Pyrexia |
3.3% |
|